|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 7
Zeitschriftenartikel
Lorenzen, Sylvie; Quante, Michael; Rauscher, Isabel; Slotta-Huspenina, Julia; Weichert, Wilko; Feith, Marcus; Friess, Helmut; Combs, Stefanie E.; Weber, Wolfgang A.; Haller, Bernhard; Angele, Martin; Albertsmeier, Markus; Blankenstein, Christiane; Kasper, Stefan; Schmid, Roland M.; Bassermann, Florian; Schwaiger, Markus; Liffers, Sven-Thorsten und Siveke, Jens T.
(2022):
PET-directed combined modality therapy for gastroesophageal junction cancer: Results of the multicentre prospective MEMORI trial of the German Cancer Consortium (DKTK).
In: European Journal of Cancer, Bd. 175: S. 99-106
Ilhan, Harun; Kroenke, Markus; Wurzer, Alexander; Unterrainer, Marcus; Heck, Matthias; Belka, Claus; Knorr, Karina; Langbein, Thomas; Rauscher, Isabel; Schmidt-Hegemann, Nina -Sophie; Schiller, Kilian; Bartenstein, Peter; Wester, Hans-Jürgen und Eiber, Matthias
(2022):
F-18-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective Study.
In: Journal of Nuclear Medicine, Bd. 63, Nr. 8: S. 1208-1214
Harder, Felix N.; Jungmann, Friederike; Kaissis, Georgios A.; Lohoefer, Fabian K.; Ziegelmayer, Sebastian; Havel, Daniel; Quante, Michael; Reichert, Maximillian; Schmid, Roland M.; Demir, Ihsan Ekin; Friess, Helmut; Wildgruber, Moritz; Siveke, Jens; Muckenhuber, Alexander; Steiger, Katja; Weichert, Wilko; Rauscher, Isabel; Eiber, Matthias; Makowski, Marcus R. und Braren, Rickmer F.
(2021):
[F-18]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma.
In: EJNMMI Research, Bd. 11, Nr. 1, 70
Fendler, Wolfgang P.; Weber, Manuel; Iravani, Amir; Hofman, Michael S.; Calais, Jeremie; Czernin, Johannes; Ilhan, Harun; Saad, Fred; Small, Eric J.; Smith, Matthew R.; Perez, Paola M.; Hope, Thomas A.; Rauscher, Isabel; Londhe, Anil; Lopez-Gitlitz, Angela; Cheng, Shinta; Maurer, Tobias; Herrmann, Ken; Eiber, Matthias und Hadaschik, Boris
(2019):
Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer.
In: Clinical Cancer Research, Bd. 25, Nr. 24: S. 7448-7454
Calais, Jeremie; Czernin, Johannes; Cao, Minsong; Kishan, Amar U.; Hegde, John V.; Shaverdian, Narek; Sandler, Kiri; Chu, Fang-I; King, Chris R.; Steinberg, Michael L.; Rauscher, Isabel; Schmidt-Hegemann, Nina-Sophie; Pöppel, Thorsten; Hetkamp, Philipp; Ceci, Francesco; Herrmann, Ken; Fendler, Wolfgang P.; Eiber, Matthias und Nickols, Nicholas G.
(2018):
68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.
In: Journal of Nuclear Medicine, Bd. 59, Nr. 2: S. 230-237
Schwarzenböck, Sarah M.; Rauscher, Isabel; Bluemel, Christina; Fendler, Wolfgang P.; Rowe, Steven P.; Pomper, Martin G.; Asfhar-Oromieh, Ali; Herrmann, Ken und Eiber, Matthias
(2017):
PSMA Ligands for PET Imaging of Prostate Cancer.
In: Journal of Nuclear Medicine, Bd. 58, Nr. 10: S. 1545-1552
Rauscher, Isabel; Maurer, Tobias; Fendler, Wolfgang P.; Sommer, Wieland H.; Schwaiger, Markus und Eiber, Matthias
(2016):
Ga-68-PSMA ligand PET/CT in patients with prostate cancer: How we review and report.
In: Cancer Imaging
16:14
[PDF, 1MB]